Novocure Limited (NVCR)
Total Valuation
Novocure has a market cap or net worth of $8.54 billion. The enterprise value is $8.16 billion.
Market Cap | 8.54B |
Enterprise Value | 8.16B |
Important Dates
The latest earnings date was Thursday, July 28, 2022, before market open.
Last Earnings Date | Jul 28, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
Novocure has 107.67 million shares outstanding. The number of shares has increased by 1.10% in one year.
Shares Outstanding | 107.67M |
Shares Change (YoY) | +1.10% |
Shares Change (QoQ) | +0.42% |
Owned by Insiders (%) | 13.27% |
Owned by Institutions (%) | 78.11% |
Float | 89.99M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 909.09 |
PS Ratio | 15.66 |
Forward PS | 14.14 |
PB Ratio | 19.33 |
P/FCF Ratio | 354.43 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 14.97 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 338.98 |
Financial Position
The company has a current ratio of 8.08, with a Debt / Equity ratio of 1.31.
Current Ratio | 8.08 |
Quick Ratio | 7.87 |
Debt / Equity | 1.31 |
Debt / EBITDA | n/a |
Debt / FCF | 23.97 |
Financial Efficiency
Return on equity (ROE) is -16.00% and return on invested capital (ROIC) is -4.40%.
Return on Equity (ROE) | -16.00% |
Return on Assets (ROA) | -6.00% |
Return on Capital (ROIC) | -4.40% |
Revenue Per Employee | $467,208 |
Profits Per Employee | -$58,472 |
Employee Count | 1,167 |
Asset Turnover | 0.48 |
Inventory Turnover | 4.13 |
Taxes
In the past 12 months, Novocure has paid $6.26 million in taxes.
Income Tax | 6.26M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.65% in the last 52 weeks. The beta is 0.87, so Novocure's price volatility has been lower than the market average.
Beta (1Y) | 0.87 |
52-Week Price Change | -39.65% |
50-Day Moving Average | 74.47 |
200-Day Moving Average | 75.42 |
Average Volume (30 Days) | 634,445 |
Short Selling Information
The latest short interest is 6.78 million, so 6.29% of the outstanding shares have been sold short.
Short Interest | 6.78M |
Short % of Shares Out | 6.29% |
Short % of Float | 7.53% |
Short Ratio (days to cover) | 14.37 |
Income Statement
In the last 12 months, Novocure had revenue of $545.23 million and -68.24 million in losses. Earnings per share was -$0.57.
Revenue | 545.23M |
Gross Profit | 429.11M |
Operating Income | -53.88M |
Pretax Income | -61.98M |
Net Income | -68.24M |
EBITDA | -43.22M |
EBIT | -53.88M |
Earnings Per Share (EPS) | -$0.57 |
Balance Sheet
The company has $949.27 million in cash and $577.22 million in debt, giving a net cash position of $372.04 million or $3.46 per share.
Cash & Cash Equivalents | 949.27M |
Total Debt | 577.22M |
Net Cash | 372.04M |
Net Cash Per Share | $3.46 |
Book Value | 441.67M |
Book Value Per Share | 4.10 |
Working Capital | 959.16M |
Cash Flow
In the last 12 months, operating cash flow was $50.88 million and capital expenditures -$26.80 million, giving a free cash flow of $24.08 million.
Operating Cash Flow | 50.88M |
Capital Expenditures | -26.80M |
Free Cash Flow | 24.08M |
FCF Per Share | $0.22 |
Margins
Gross margin is 78.70%, with operating and profit margins of -9.88% and -12.52%.
Gross Margin | 78.70% |
Operating Margin | -9.88% |
Pretax Margin | -11.37% |
Profit Margin | -12.52% |
EBITDA Margin | -7.93% |
EBIT Margin | -9.88% |
FCF Margin | 4.42% |
Dividends & Yields
Novocure does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -0.80% |
FCF Yield | 0.28% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.10% |
Shareholder Yield | -1.10% |
Analyst Forecast
The average price target for Novocure is $96.14, which is 21.27% higher than the current price. The consensus rating is "Buy".
Price Target | $96.14 |
Price Target Difference | 21.27% |
Analyst Consensus | Buy |
Analyst Count | 14 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |